Table 3. Patient-reported outcomes of patients with upper extremity lymphedema who underwent gastroepiploic vascularized lymph node flap transfer.
| Characteristics | Middle buried (n=7) | Distal (n=7) | P value | |||
|---|---|---|---|---|---|---|
| Preop | Postop | Preop | Postop | |||
| Life impact (LLISv2) | ||||||
| Physical concerns | 3.4±0.5 | 1.3±0.9 | 3.5±0.1 | 1.2±0.3 | 0.05α | |
| Psychosocial concerns | 2.2±0.5 | 1.5±1.1 | 2.8±0.2 | 1.5±0.4 | 0.05α | |
| Functional concerns | 2.6±1.1 | 1.9±1.7 | 3.0±0.2 | 1.2±0.6 | 0.05α | |
| Scar | ||||||
| Satisfaction with appearance | – | 1.6±0.1 | – | 2.6±0.3 | 0.04*β | |
| Satisfaction with symptoms | – | 1.0±0.1 | – | 2.1±0.3 | 0.03*β | |
Data presented as mean and standard deviation. *, statistically significant; α, obtained by comparing the median differences (pre and postoperatively values) for both groups using the Wilcoxon signed rank test; β, obtained by comparing the medians of both groups using the Wilcoxon rank sum test. LLISv2, Lymphedema Life Impact Scale-v2.